EBUSCO HOLDING NV (EBUS.AS)

NL0015000CZ2 - Common Stock

0.834  -0.02 (-1.77%)

Fundamental Rating

2

EBUS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 102 industry peers in the Machinery industry. EBUS may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, EBUS is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

EBUS had negative earnings in the past year.
In the past year EBUS has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: EBUS reported negative net income in multiple years.
In the past 5 years EBUS always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -50.80%, EBUS is doing worse than 98.00% of the companies in the same industry.
EBUS's Return On Equity of -120.90% is on the low side compared to the rest of the industry. EBUS is outperformed by 94.00% of its industry peers.
Industry RankSector Rank
ROA -50.8%
ROE -120.9%
ROIC N/A
ROA(3y)-18.36%
ROA(5y)-6.06%
ROE(3y)-28.84%
ROE(5y)-0.21%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

EBUS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

EBUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EBUS has more shares outstanding
EBUS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for EBUS is higher compared to a year ago.

2.2 Solvency

EBUS has an Altman-Z score of -1.83. This is a bad value and indicates that EBUS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.83, EBUS is not doing good in the industry: 89.00% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.11 indicates that EBUS is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.11, EBUS belongs to the best of the industry, outperforming 84.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z -1.83
ROIC/WACCN/A
WACC6.56%

2.3 Liquidity

A Current Ratio of 1.30 indicates that EBUS should not have too much problems paying its short term obligations.
EBUS has a Current ratio of 1.30. This is in the lower half of the industry: EBUS underperforms 65.00% of its industry peers.
EBUS has a Quick Ratio of 1.30. This is a bad value and indicates that EBUS is not financially healthy enough and could expect problems in meeting its short term obligations.
EBUS has a worse Quick ratio (0.56) than 88.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.56

6

3. Growth

3.1 Past

The earnings per share for EBUS have decreased strongly by -166.63% in the last year.
EBUS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.07%.
EBUS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.83% yearly.
EPS 1Y (TTM)-166.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65%
Revenue 1Y (TTM)-15.07%
Revenue growth 3Y0.81%
Revenue growth 5Y36.83%
Sales Q2Q%-8.91%

3.2 Future

The Earnings Per Share is expected to grow by 24.91% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 48.07% on average over the next years. This is a very strong growth
EPS Next Y9.85%
EPS Next 2Y37.02%
EPS Next 3Y29.07%
EPS Next 5Y24.91%
Revenue Next Year38.81%
Revenue Next 2Y48.63%
Revenue Next 3Y39.61%
Revenue Next 5Y48.07%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

EBUS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year EBUS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as EBUS's earnings are expected to grow with 29.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.02%
EPS Next 3Y29.07%

0

5. Dividend

5.1 Amount

EBUS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EBUSCO HOLDING NV

AMS:EBUS (9/16/2024, 2:00:07 PM)

0.834

-0.02 (-1.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap56.91M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.8%
ROE -120.9%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.3
Quick Ratio 0.56
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-166.63%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y9.85%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-15.07%
Revenue growth 3Y0.81%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y